Utku Furuncuoğlu

ORCID: 0000-0003-0773-910X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Retinal Diseases and Treatments
  • Retinal Imaging and Analysis
  • Intraocular Surgery and Lenses
  • Corneal surgery and disorders
  • Retinopathy of Prematurity Studies
  • Child Abuse and Related Trauma
  • Glaucoma and retinal disorders
  • Ocular Diseases and Behçet’s Syndrome
  • Neonatal Respiratory Health Research
  • Ocular Infections and Treatments
  • Facial Trauma and Fracture Management
  • Renal and Vascular Pathologies
  • Neonatal Health and Biochemistry
  • Retinal and Optic Conditions

Kastamonu University
2021-2023

Bakırköy Dr.Sadi Konuk Eğitim ve Araştırma Hastanesi
2022

Sağlık Bilimleri Üniversitesi
2022

Our study evaluated macular and optic disc vascular density (VD) changes in patients diagnosed with keratoconus, as compared gender age-matched healthy controls, relation to the keratoconus stage.This comparative cross-sectional included adult who received a diagnosis of at Cornea Clinic. All scans consisted two 4.5 mm × images area 6 using optical coherence tomography angiography.The 67 (26 women (38.8%) 41 men (61.2%)) 74 controls (31 (41.9%) 43 (58.1%)). The mean ages group control were...

10.1177/11206721221127770 article EN European Journal of Ophthalmology 2022-09-19

Objective: To assess the real-life performance and clinical outcomes in patients with diabetic macular edema (DME). Method: The chart records were retrospectively evaluated for 42 eyes of DME, who followed two years between October 2013 2016 at Retina Unit. treated using intravitreal ranibizumab (0.5 mg/0.05 ml) years. Results: Early Treatment Diabetic Retinopathy Study (ETDRS) letter score indicated BCVA values 71.1±22.4 letters baseline, 74.1±19.1 sixth month, 76.2±16.2 first year,...

10.5222/bmj.2020.39200 article EN Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy 2020-01-01

Objective: The objective of this study is to assess the follow-up and treatment outcomes eyes with wet age-related macular degeneration (wet AMD) for two years in a real-life clinical practice setting.Methods: In total, 37 patients AMD treated 0.5 mg intravitreal ranibizumab as needed at least 2 were retrospectively evaluated.Analyses included best-corrected visual acuity (BCVA) central foveal thickness measurements (CFT) by optical coherence tomography baseline, sixth month, first year,...

10.4274/bmj.galenos.2021.29494 article EN Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy 2021-07-01
Coming Soon ...